IRONWOOD PHARMACEUTICALS, INC. — Revenue by Fiscal Year
17 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/b0b1a14c-95a6-44de-8cbc-c3f6b1401ae5/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $296.2M | 2025-01-01 – 2025-12-31 | evidence 0001104659-26-020489 |
| FY 2024 | $351.4M | 2024-01-01 – 2024-12-31 | evidence 0001558370-25-004072 |
| FY 2023 | $442.7M | 2023-01-01 – 2023-12-31 | evidence 0001558370-24-001275 |
| FY 2022 | $410.6M | 2022-01-01 – 2022-12-31 | evidence 0001558370-23-001462 |
| FY 2021 | $413.8M | 2021-01-01 – 2021-12-31 | evidence 0001558370-22-001368 |
| FY 2020 | $389.5M | 2020-01-01 – 2020-12-31 | evidence 0001558370-21-001136 |
| FY 2019 | $428.4M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-000779 |
| FY 2018 | $346.6M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-001005 |
| FY 2017 | $298.3M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-000927 |
| FY 2016 | $274.0M | 2016-01-01 – 2016-12-31 | evidence 0001558370-19-001005 |
| FY 2015 | $149.6M | 2015-01-01 – 2015-12-31 | evidence 0001047469-16-010251 |
| FY 2014 | $76.4M | 2014-01-01 – 2014-12-31 | evidence 0001047469-15-000916 |
| FY 2013 | $22.9M | 2013-01-01 – 2013-12-31 | evidence 0001047469-14-000693 |
| FY 2012 | $150.2M | 2012-01-01 – 2012-12-31 | evidence 0001047469-13-001388 |
| FY 2011 | $65.9M | 2011-01-01 – 2011-12-31 | evidence 0001047469-12-001846 |
| FY 2010 | $43.9M | 2010-01-01 – 2010-12-31 | evidence 0001047469-12-001846 |
| FY 2009 | $34.3M | 2009-01-01 – 2009-12-31 | evidence 0001047469-12-001846 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
IRONWOOD PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income